In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1537-1541

  Rolain, J M ^a   Maurin, M ^a   Vestris, G ^a   Raoult, D ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; JOSAMYCIN; OFLOXACIN; PEFLOXACIN; PRISTINAMYCIN; RIFAMPICIN; THIAMPHENICOL;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BOUTONNEUSE FEVER; DRUG EFFICACY; HYPOTHESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RICKETTSIOSIS; SPECIES DIFFERENCE; STRAIN DIFFERENCE;

EID: 0031807593     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1537     Document Type: Article

References (48)

1. Beati, L., O. Peter, W. Burgdorfer, A. Aeschlimann, and D. Raoult. 1993. Confirmation that Rickettsia helvetica sp. nov. is a distinct species of the spotted fever group of rickettsiae. Int. J. Syst. Bacteriol. 43:521-526.
2. Beati, L., and D. Raoult. 1993. Rickettsia massiliae sp. nov., a new spotted fever group Rickettsia. Int. J. Syst. Bacteriol. 43:839-840.
3. Beati L., V. Roux, A. Ortuno, J. Castella, F. Segura Porta, and D. Raoult. 1996. Phenotypic and genotypic characterization of spotted fever group rickettsiae isolated from Catalan Rhipicephalus sanguineus ticks. J. Clin. Microbiol. 34:2688-2694.
4. Beati, L., M. Meskini, B. Thiers, and D. Raoult. 1997. Rickettsia aeschlimannii sp. nov., a new spotted fever group rickettsia associated with Hyalomma marginatum ticks. Int. J. Syst. Bacteriol. 47:548-554.
5. Bella, F., B. Font, S. Uriz, T. Muñoz, E. Espejo, J. Travena, J. A. Serrano, and F. Segura. 1990. Randomized trial of doxycycline versus josamycin for Mediterranean spotted fever. Antimicrob. Agents Chemother. 34:937-938.
6. Bella, F., E. Espero, S. Uriz, J. A. Serrano, M. A. Allegre, and J. Tort. 1991. Randomized trial of 5-day rifampin versus 1-day doxycycline therapy for MSF. J. Infect. Dis. 164:433-434.
7. Bernard, E., M. Carles, S. Politano, C. Laffont, and P. Dellamonica. 1989. Rickettsiosis caused by Rickettsia conorii: treatment with ofloxacin. Rev. Infect. Dis. 11(Suppl. 5):989.
8. Carter, P. E., F. J. R. Abadi, D. E. Yakubu, and T. H. Pennington. 1994. Molecular characterization or rifampin-resistant Neisseria meningitidis. Antimicrob. Agents Chemother. 38:1256-1261.
9. Gimenez, D. F. 1964. Staining rickettsiae in yolk-sac cultures. Stain. Technol. 39:135-140.
10. Gudiol, F., R. Pallares, J. Carratala, F. Bolao, J. Ariza, G. Rufi, and P. F. Viladrich. 1989. Randomized double-blind evaluation of ciprofloxacin and doxycycline for Mediterranean spotted fever. Antimicrob. Agents Chemother. 33:987-988.
11. Honore, N., and S. T. Cole. 1993. Molecular basis of rifampin resistance in Mycobacterium leprae. Antimicrob. Agents Chemother. 37:414-418.
12. Ives, T. J., P. Manzewitsch, R. L. Regnery, J. D. Butts, and M. Kebede. 1997. In vitro susceptibilities of Bartonella henselae, B. quintana, B. elizabethae, Rickettsia rickettsii, R. conorii, R. akari, and R. prowazekii to macrolide antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers. Antimicrob. Agents Chemother. 41:578-582.
13. Jabarit-Aldighieri, N., H. Torres, and D. Raoult. 1992. Susceptibility of Rickettsia conorii, R. rickettsii, and Clostridium burnetii to PD 127,391, PD 131,628, pefloxacin, ofloxacin, and ciprofloxacin. Antimicrob. Agents Chemother. 36:2529-2532.
14. Janbon, F., O. Jonquet, J. Reynes, and A. Bertrand. 1989. Use of pefloxacin in the treatment of rickettsiosis and coxiellosis. Rev. Infect. Dis. 11(Suppl. 5): 990-991.
15. Jin, D. J., and C. A. Gross. 1988. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that leads to rifampin resistance. J. Mol. Biol. 202:45-58.
16. Kelly, P. J., D. Raoult, and P. R. Mason. 1991. Isolation of spotted fever group rickettsiae from triturated ticks using a modification of the centrifugation shell-vial technique. Trans. R. Soc. Trop. Med. Hyg. 85:397-398.
17. Kelly, P. J., L. Beati, P. R. Mason, L. A. Matthewman, V. Roux, and D. Raoult. 1996. Rickettsia africae sp. nov., the etiologic agent of African tick bite fever. Int. J. Syst. Bacteriol. 46:611-614.
18. Keysary, A., A. Itzhaki, E. Rubinstein, C. Oron, and G. Keren. 1996. The in vitro antirickettsial activity of macrolides. J. Antimicrob. Chemother. 38:727-731.
19. Marrero, M., and D. Raoult. 1989. Centrifugation-shell vial technique for rapid detection of Mediterranean spotted fever rickettsia in blood culture. Am. J. Trop. Med. Hyg. 40:197-199.
20. Maurin, M., and D. Raoult. 1993. In vitro susceptibilities of spotted lever group rickettsiae and Coxiella bumetii to clarithromycin. Antimicrob. Agents Chemother. 37:2633-2637.
21. Maurin, M., and D. Raoult. 1997. Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, Israeli spotted fever group rickettsiae and Coxiella bumetii. J. Antimicrob. Chemother. 39:725-730.
22. Munoz Espin, T., P. Lopez Pares, E. Espejo Arenas, B. Font Creus, I. Martinez Vila, J. Traveria Casanova, F. Segura Porta, and F. Bella Cueto. 1986. Erythromycin versus tetracycline for treatment of Mediterranean spotted fever. Arch. Dis. Child. 61:1027-1029.
23. Raoult, D., M. J. Jean-Pastor, B. Xeridat, J. M. Garnier, P. J. Weiller, G. Garcin Y. Privat, H. Gallais, and P. Casanova. 1983. La fièvre boutonneuse méditerranéenne. A propos de 154 cas récents. Ann. Dermatol. Venerol. 110:909-914.
24. Raoult, D., P. Rousselier, V. Galicher, R. Perez, and J. Tamalet. 1986. In vitro susceptibility of Rickettsia conorii to ciprofloxacin as determined by suppressing lethality in chicken embryos and by plaque assay. Antimicrob. Agents Chemother. 29:424-425.
25. Raoult, D., H. Gallais, P. De Micco, and P. Casanova. 1986. Ciprofloxacin therapy for Mediterranean spotted fever. Antimicrob. Agents Chemother. 30:606-607.
26. Raoult, D., P. Rousselier, G. Vestris, and J. Tamalet. 1987. In vitro susceptibility of Rickettsia rickettsii and Rickettsia conorii as determined by plaque assay and by microplaque colorimetric assay. J. Infect. Dis. 155:1059-1062.
27. Raoult, D., P. Rousselier, and J. Tamalet. 1988. In vitro evaluation of josamycin, erythromycin, and spiramycin against Rickettsia rickettsii and Rickettsia conorii. Antimicrob. Agents Chemother. 32:255-256.
28. Raoult, D., and D. H. Walker. 1990. Rickettsia rickettsii and other spotted fever group rickettsiae, p. 1465-1469. In G. L. Mandell, R. J. Gordon, and J. E. Bennett (ed.), Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone, New York, N.Y.
29. Raoult, D., and M. Drancourt. 1991. Antimicrobial therapy of nekettsial diseases Antimicrob. Agents Chemother. 35:2457-2462.
30. Raoult, D., P. Bres, M. Drancourt, and G. Vestris. 1991. In vitro susceptibilities of Coxiella burnetti, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin. Antimicrob. Agents Chemother. 35:88-91.
31. Raoult, D., P. Brouqui, and V. Roux. 1996. A new proposed fever group rickettsiosis. Lancet 348:412.
32. Raoult, D., P. Berbis, V. Roux, W. Xu, and M. Maurin. 1997. A new tick-transmitted disease due to Rickettsia slovaca. Lancet 350:112-113.
33. Raoult, D., and V. Roux. 1997. Rickettsioses as paradigms of new or emerging infectious diseases. Clin. Microbiol. Rev. 10:694-719.
34. Roux, V., and D. Raoult. 1995. Phylogenetic analysis of the genus Rickettsia by 16S rDNA sequencing. Res. Microbiol. 146:385-396.
35. Roux, V., E. Rydkina, M. Eremeeva, and D. Raoult. 1996. Citrate synthase gene comparison, a new tool for phylogenetic analysis, and its application for the rickettsiae. Int. J. Syst. Bacteriol. 47:252-261.
36. Ruiz Beltran, R., and J. I. Herrero Herrero. 1992. Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever. Eur. J. Clin. Microbiol. Infect. Dis. 11:427-431.
37. Ruiz Beltran, R., and J. I. Herrero Herrero. 1992. Deleterious effect of trimethoprim-sulfamethoxazole in Mediterranean spotted fever. Antimicrob. Agents Chemother. 36:1342-1344.
38. Schriefer, M. E., J. B. J. Sacci, J. S. Dumler, M. G. Bullen, and A. F. Azad. 1994. Identification of a novel rickettsial infection in a patient diagnosed with murine typhus. J. Clin. Microbiol. 32:949-954.
39. Shaked, Y., Y. Samra, M. K. Maier, and E. Rubinstein. 1989. Relapse of rickettsial Mediterranean spotted fever and murine typhus after treatment with chloramphenicol. J. Infect. Dis. 18:35-37.
40. Stewart, R. S. 1991. Flinders Island spotted fever: a newly recognised endemic focus of tick typhus in Bass Strait. Part 1. Clinical and epidemiological features. Med. J. Aust. 154:94-99.
41. Tarasevich, I. V., V. Makarova, A. Stepanov, E. Mistkarova, N. M. Balayeva, and D. Raoult. 1991. Astrakhan fever: new spotted fever group rickettsiosis. Lancet 337:172-173.
42. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Coslton, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
43. Uchida, T., T. Uchiyama, K. Kumano, and D. H. Walker. 1992. Rickettsia japonica sp. nov., the etiological agent of spotted fever group rickettsiosis in Japan. Int. J. Syst. Bacteriol. 42:303-305.
44. Wike, D. A., G. Tallent, M. G. Peacock, and R. A. Ormsbee. 1972. Studies of the rickettsial plaque assay technique. Infect. Immun. 5:715-722.
45. Wisseman, C. L., Jr., A. D. Waddell, and W. T. Walsh. 1974. In vitro studies of the action of antibiotics on Rickettsia prowazekii by two basic methods of cell culture. J. Infect. Dis. 130:564-574.
46. Wisseman, C. L., Jr., D. J. Silverman, A. Waddell, and D. T. Brown. 1982. Penicillin-induced unstable intracellular formation of spheroplasts by rickettsiae. J. Infect. Dis. 146:147-158.
47. Yagupsky, P., and E. M. Gross. 1985. Relapse of Israeli spotted fever treated with doxycycline. Trans. R. Soc. Trop. Med. Hyg. 79:139-140.
48. Yu, X., M. Fan, G. Xu, Q. Liu, and D. Raoult. 1993. Genotypic and antigenic identification of two new strains of spotted fever group rickettsiae isolated from China. J. Clin. Microbiol. 31:83-88.